Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Summit Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +1 vs. Q2 2022
- Shares held
- 3.18M
- −5.28M (−62.4%) vs. Q2 2022
- Total value
- $3.78M
- −$4.68M (−55.3%) vs. Q2 2022
- New holders
- 11
- 14 more added
- Sold out
- 10
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $1.98B |
| Q1 2026 | 222 | $2.25B |
| Q4 2025 | 206 | $2.06B |
| Q3 2025 | 232 | $2.13B |
| Q2 2025 | 226 | $2.08B |
| Q1 2025 | 202 | $1.91B |
| Q4 2024 | 196 | $1.65B |
| Q3 2024 | 164 | $1.85B |
| Q2 2024 | 121 | $563.0M |
| Q1 2024 | 103 | $205.5M |
| Q4 2023 | 95 | $84.4M |
| Q3 2023 | 91 | $60.4M |
| Q2 2023 | 96 | $87.6M |
| Q1 2023 | 86 | $37.0M |
| Q4 2022 | 57 | $34.5M |
| Q3 2022 | 42 | $3.78M |
| Q2 2022 | 41 | $8.46M |
| Q1 2022 | 48 | $27.4M |
| Q4 2021 | 52 | $30.0M |
| Q3 2021 | 51 | $55.3M |
| Q2 2021 | 54 | $82.4M |
| Q1 2021 | 38 | $54.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Summit Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 334 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bradley & Co. Private Wealth Management, LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,300 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,159 | $1.38K | 0.00% | +1,159 | New |
| Barclays PLC | 2,089 | $2.00K | 0.00% | +961+85.2% | Added |
| Bank of America Corp | 1,684 | $2.00K | 0.00% | +1,478+717.5% | Added |
| China Universal Asset Management Co., Ltd. | 1,885 | $2.00K | 0.00% | +1,885 | New |
| Adirondack Trust Co | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,549 | $3.00K | 0.00% | +829+48.2% | Added |
| National Bank of Canada | 3,241 | $4.00K | 0.00% | 00.0% | Unchanged |
| Osterweis Capital Management Inc | 5,000 | $6.00K | 0.00% | +5,000 | New |
| Evoke Wealth, LLC | 8,000 | $10.0K | 0.00% | +3,000+60.0% | Added |
| Tower Research Capital LLC (TRC) | 11,391 | $14.0K | 0.00% | +2,028+21.7% | Added |
| JPMorgan Chase & Co | 12,392 | $15.0K | 0.00% | +7,257+141.3% | Added |
| Vance Wealth, Inc. | 13,299 | $16.0K | 0.01% | 00.0% | Unchanged |
| Bender Robert & Associates | 14,059 | $17.0K | 0.01% | 00.0% | Unchanged |
| Man Group plc | 15,719 | $19.0K | 0.00% | +15,719 | New |
| Qube Research & Technologies Ltd | 17,120 | $20.0K | 0.00% | −1,691−9.0% | Reduced |
| Inscription Capital, LLC | 17,000 | $20.0K | 0.01% | 00.0% | Unchanged |
| ProShare Advisors LLC | 16,925 | $20.0K | 0.00% | +16,925 | New |
| Two Sigma Securities, LLC | 17,092 | $20.0K | 0.00% | +17,092 | New |
| Cowen and Company, LLC | 17,249 | $21.0K | 0.00% | −800−4.4% | Reduced |
| Jane Street Group, LLC | 20,259 | $24.0K | 0.00% | +20,259 | New |
| Wells Fargo & Company | 21,100 | $25.0K | 0.00% | +200+1.0% | Added |
| Northern Trust Corp | 22,903 | $27.0K | 0.00% | +22,903 | New |
| Group One Trading, L.P. | 24,714 | $29.0K | 0.00% | +24,714 | New |
| Bank of Montreal | 28,500 | $35.0K | 0.00% | +28,500 | New |
| Hoylecohen, LLC | 30,432 | $36.0K | 0.00% | 00.0% | Unchanged |
| Levin Capital Strategies, L.P. | 39,176 | $47.0K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 40,374 | $48.0K | 0.00% | +29,774+280.9% | Added |
| Mercer Global Advisors Inc | 42,300 | $50.0K | 0.00% | +2,100+5.2% | Added |
| UBS Group AG | 49,245 | $58.0K | 0.00% | −14,091−22.2% | Reduced |
| Goldman Sachs Group Inc | 60,740 | $72.0K | 0.00% | +26,347+76.6% | Added |
| Susquehanna International Group, LLP | 81,707 | $97.0K | 0.00% | +58,070+245.7% | Added |
| Bridgeway Capital Management, LLC | 89,100 | $106.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 140,660 | $167.0K | 0.00% | +140,660 | New |
| Geode Capital Management, LLC | 324,292 | $385.0K | 0.00% | +269,937+496.6% | Added |
| Morgan Stanley | 351,337 | $418.0K | 0.00% | +142,144+67.9% | Added |
| BlackRock Inc. | 421,086 | $500.0K | 0.00% | +118,878+39.3% | Added |
| Millennium Management LLC | 431,560 | $514.0K | 0.00% | −25,908−5.7% | Reduced |
| Vanguard Group Inc | 775,922 | $923.0K | 0.00% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −5,599,407−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −100,722−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −81,559−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −56,743−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −49,118−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,355−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |